Intralesional immunotherapy for melanoma.

@article{Hersey2014IntralesionalIF,
  title={Intralesional immunotherapy for melanoma.},
  author={Peter Hersey and Stuart J Gallagher},
  journal={Journal of surgical oncology},
  year={2014},
  volume={109 4},
  pages={320-6}
}
Intralesional immunotherapy of melanoma has two complementary aims. One is to cause regression of the injected metastasis. The other is to incite or modulate systemic immune responses in such a way that non-injected metastases will also undergo regression. A number of phase 1 and phase II studies with cytokines, viral, or bacterial agents have been conducted but their use has remained sporadic and has not progressed to become established treatments. Two treatments have progressed to randomized… CONTINUE READING